News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
341,766 Results
Type
Article (12516)
Company Profile (22)
Press Release (329228)
Section
Business (137370)
Career Advice (786)
Deals (25299)
Drug Delivery (40)
Drug Development (34365)
Employer Resources (49)
FDA (6130)
Job Trends (7272)
News (201908)
Policy (13932)
Tag
Academia (639)
Alliances (20560)
Alzheimer's disease (586)
Approvals (6154)
Artificial intelligence (63)
Bankruptcy (272)
Best Places to Work (6097)
Breast cancer (96)
Cancer (811)
Career advice (681)
Cell therapy (171)
Clinical research (28582)
Collaboration (269)
Compensation (79)
COVID-19 (864)
C-suite (85)
Data (840)
Diabetes (84)
Diagnostics (3009)
Earnings (83938)
Events (46221)
Executive appointments (351)
FDA (6585)
Funding (457)
Gene therapy (115)
GLP-1 (278)
Government (1428)
Healthcare (8958)
Infectious disease (907)
Inflammatory bowel disease (58)
Interviews (153)
IPO (13588)
Job creations (1442)
Job search strategy (574)
Layoffs (242)
Legal (3511)
Lung cancer (105)
Manufacturing (107)
Medical device (7105)
Medtech (7106)
Mergers & acquisitions (12020)
Metabolic disorders (240)
Neuroscience (747)
NextGen: Class of 2025 (3285)
Non-profit (1279)
Northern California (1129)
Obesity (115)
Opinion (129)
Patents (84)
People (28246)
Phase I (8417)
Phase II (12941)
Phase III (10151)
Pipeline (607)
Postmarket research (718)
Preclinical (3078)
Radiopharmaceuticals (145)
Rare diseases (135)
Real estate (1895)
Regulatory (9765)
Research institute (614)
Resumes & cover letters (84)
Series A (98)
Series B (65)
Southern California (1106)
Startups (2688)
United States (10724)
Vaccines (243)
Weight loss (65)
Date
Today (69)
Last 7 days (454)
Last 30 days (1601)
Last 365 days (19462)
2025 (3113)
2024 (19952)
2023 (23105)
2022 (27685)
2021 (29563)
2020 (28183)
2019 (22282)
2018 (16996)
2017 (17908)
2016 (15451)
2015 (19192)
2014 (14400)
2013 (11553)
2012 (12250)
2011 (12477)
2010 (11761)
Location
Africa (290)
Arizona (82)
Asia (18840)
Australia (2910)
California (2710)
Canada (1063)
China (132)
Colorado (133)
Connecticut (142)
Europe (42539)
Florida (490)
Georgia (109)
Illinois (234)
Indiana (142)
Japan (65)
Maryland (401)
Massachusetts (1827)
Michigan (151)
Minnesota (186)
New Jersey (902)
New York (898)
North Carolina (519)
Northern California (1129)
Ohio (83)
Pennsylvania (636)
South America (488)
Southern California (1106)
Texas (413)
Utah (91)
Virginia (59)
Washington State (326)
341,766 Results for "fina biosolutions llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development
October 29, 2024
·
3 min read
Lone Star Bio
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization, for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein.
July 27, 2023
·
3 min read
Press Releases
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 19, 2025
·
1 min read
Business
Emergent BioSolutions Reports First Quarter 2024 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
31 min read
Press Releases
Autoimmunity BioSolutions to Present at the 2025 Sequire Investor Summit in Puerto Rico
January 16, 2025
·
2 min read
Press Releases
Olfactive Biosolutions Granted Second Patent to Repurpose Food Molecules for Treatment of Hypertension
February 11, 2025
·
3 min read
Press Releases
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
November 7, 2024
·
41 min read
Press Releases
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
January 14, 2025
·
4 min read
Press Releases
STELLUS CAPITAL MANAGEMENT, LLC PROVIDES UNITRANCHE FINANCING IN SUPPORT OF NORTHLANE CAPITAL PARTNERS’ INVESTMENT IN UNITED STATES DRUG TESTING LABORATORIES INC.
January 28, 2025
·
1 min read
Business
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2023.
March 6, 2024
·
39 min read
1 of 34,177
Next
